Division of Rheumatology, Department of Medicine, NYU School of Medicine, New York, NY, USA.
Weill Cornell Medicine, Jill Roberts Institute for Research in Inflammatory Bowel Disease, New York, NY, USA.
Int J Rheum Dis. 2021 Apr;24(4):582-590. doi: 10.1111/1756-185X.14081. Epub 2021 Feb 2.
Prevalence of sacroiliitis in Crohn's disease (CD) is variable depending on defining criteria. This study utilized standardized sacroiliac joint (SIJ) magnetic resonance imaging (MRI) to identify sacroiliitis in CD patients and its association with clinical and serological markers.
Consecutive adult subjects with CD prospectively enrolled from an inflammatory bowel disease clinic underwent SIJ MRI. Data collected included CD duration, history of joint/back pain, human leukocyte antigen-B27 status, Bath Ankylosing Spondylitis Metrology Index (BASMI), Bath Ankylosing Spondylitis Disease Activity Index, Harvey Bradshaw Index (HBI) for activity of CD, Ankylosing Spondylitis Disease Activity Score, and various serologic markers of inflammation. Three blinded readers reviewed MRIs for active and structural lesions according to the Spondyloarthritis Research Consortium of Canada modules.
Thirty-three CD patients were enrolled: 76% female, 80% White, median age 36.4 years (interquartile range 27.2-49.0), moderate CD activity (mean HBI 8.8 ± SD 4.5). Nineteen subjects (58%) reported any back pain, 13 of whom had inflammatory back pain. Four subjects (12%) showed sacroiliitis using global approach and 6 (18%) met Assessment of SpondyloArthritis international Society MRI criteria of sacroiliitis. Older age (mean 51.2 ± SD 12.5 vs. 37.2 ± 14; P = .04), history of dactylitis (50.0% vs. 3.4%, P = .03) and worse BASMI (4.1 ± 0.7 vs. 2.4 ± 0.8, P ≤ .001) were associated with MRI sacroiliitis; no serologic measure was associated.
There were 12%-18% of CD patients who had MRI evidence of sacroiliitis, which was not associated with back pain, CD activity or serologic measures. This data suggests that MRI is a useful modality to identify subclinical sacroiliitis in CD patients.
根据不同的定义标准,克罗恩病(CD)中存在的骶髂关节炎的流行程度有所不同。本研究采用标准化的骶髂关节(SIJ)磁共振成像(MRI)来识别 CD 患者的骶髂关节炎,并研究其与临床和血清学标志物的关系。
前瞻性地从炎症性肠病门诊招募了连续的成年 CD 患者,进行 SIJ MRI 检查。收集的数据包括 CD 病程、关节/背痛史、人类白细胞抗原-B27 状态、Bath 强直性脊柱炎计量指数(BASMI)、Bath 强直性脊柱炎疾病活动指数、CD 活动 Harvey Bradshaw 指数(HBI)、强直性脊柱炎疾病活动评分以及各种炎症的血清学标志物。三位盲法阅片者根据加拿大脊柱关节炎研究协会模块,对 MRI 上的活动性和结构性病变进行评估。
共纳入 33 例 CD 患者:76%为女性,80%为白人,中位年龄 36.4 岁(四分位距 27.2-49.0),CD 处于中度活动期(平均 HBI 8.8±SD 4.5)。19 例(58%)患者报告有任何背痛,其中 13 例有炎症性背痛。4 例(12%)患者通过整体评估方法显示骶髂关节炎,6 例(18%)符合评估脊柱关节炎国际协会的骶髂关节炎 MRI 标准。年龄较大(平均 51.2±SD 12.5 岁 vs. 37.2±14 岁;P=0.04)、有指(趾)炎病史(50.0% vs. 3.4%,P=0.03)和更差的 BASMI(4.1±0.7 vs. 2.4±0.8,P≤0.001)与 MRI 骶髂关节炎相关;没有血清学指标与之相关。
有 12%-18%的 CD 患者有 MRI 骶髂关节炎的证据,但与背痛、CD 活动度或血清学指标无关。这些数据表明,MRI 是识别 CD 患者亚临床骶髂关节炎的有用方法。